COVID-19 vaccination mandate needs “strong justification” and fairness

Publicly released:
Australia; NSW; VIC; WA

Mandatory vaccination proposals must be backed by “strong justification”, and less restrictive avenues to increase uptake must be “meaningfully attempted” first, argue Australian experts. They outline the prerequisites that must be met for a successful and fair mandate to be put in place including that vaccine supply should be sufficient and access easy. 

Media release

From: Medical Journal of Australia (MJA)

COVID VACCINATION MANDATE NEEDS “STRONG JUSTIFICATION” AND FAIRNESS

MANDATORY vaccination proposals must be backed by “strong justification”, and less restrictive avenues to increase uptake must be “meaningfully attempted” first, according to authors of an article published by the Medical Journal of Australia.

Professor Julie Leask and colleagues from the Collaboration on Social Science in Immunisation, wrote that a range of issues must be considered before COVID-19 vaccine mandates were introduced.

“Because they are more coercive than other interventions to increase vaccination

coverage, mandates demand stronger ethical justification,” Leask and colleagues wrote.

“Policy makers should balance rights of individuals and the promotion of public good whilst carefully considering the epidemiological, programmatic, and legal issues.”

The authors outlined the following prerequisites for a successful and fair mandate:

·         The mandate should be legal – in most settings it must have legislative support. Fair Work Australia provides general guidance in workplace settings;

·         The burden of disease should be high enough to justify a mandate;

·         The mandated vaccines must be safe – “Governments need to operate a no-fault vaccine injury compensation scheme to compensate those required to vaccinate in the rare occurrence of a serious adverse event”;

·         The vaccines should reduce transmission – “more justifiable when vaccinating one person helps protect others around them”;

·         Vaccine supply should be sufficient and access easy – “A penalty for not vaccinating when the government has failed to meet its service delivery obligations is unjust”;

·         Less restrictive and trust-promoting measures should come first;

·         The type of mandate should not penalise the poor unfairly – “Mandates should not compound disadvantage”;

·         Those mandating need to plan and support implementation – “systems for documenting and retrieving evidence of vaccination are essential”; and,

·         Affected populations should be considered in planning – “All mandates must include

·         exemptions for those with a valid medical reason”.

“Addressing these considerations in ways that are procedurally just can ensure that outcomes are fairer and more trusted,” Leask and colleagues concluded.

“Mandate decisions that are careful and responsive to context are more likely to avoid social harms while, ideally, helping to achieve a public good.”

All MJA media releases are open access and can be found at: https://www.mja.com.au/journal/media 

Please remember to credit The MJA.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research Wiley, Web page Please link to the article in online versions of your report
Journal/
conference:
Medical Journal of Australia
Research:Paper
Organisation/s: The University of Sydney, The University of New South Wales, Murdoch Children's Research Institute (MCRI), University of Technology Sydney (UTS), The University of Western Australia
Funder: Julie Leask and Kerrie Wiley have received a grant from NHMRC to study policy aspects of childhood vaccine refusal. Holly Seale has previously received funding for investigator driven research from NSW Ministry of Health, as well as from Sanofi Pasteur and Seqirus (not related to this project). Julie Leask sits on the Expert Advisory Group for the Victorian Department of Health and Human Services and was a temporary unpaid advisor to the Vaxzevria (previously COVID-19 Vaccine AstraZeneca) Advisory Board. Jessica Kaufman and Margie Danchin’s institution MCRI receives funding from the Commonwealth and Victorian Department of health for COVID-19 vaccine social research. Katie Attwell is a current recipient of a Discovery Early Career Researcher Award funded by the Australian Research Council of the Australian Government (DE19000158) focusing on mandatory vaccination. Katie Attwell receives funding to her institution from the Western Australia Department of Health for COVID-19 vaccine social research (Coronavax). Coronavax is also funded through a Wesfarmers Centre of Vaccines and Infectious Diseases Catalyst grant, and a Future Health Research & Innovation Fund COVID-19 Focus Grant.
Media Contact/s
Contact details are only visible to registered journalists.